Annexon, Inc. (ANNX)
NASDAQ: ANNX · Real-Time Price · USD
2.590
+0.210 (8.82%)
At close: Jul 30, 2025, 4:00 PM
2.588
-0.002 (-0.07%)
After-hours: Jul 30, 2025, 7:49 PM EDT
Annexon Market Cap
Annexon has a market cap or net worth of $284.16 million as of July 30, 2025. Its market cap has decreased by -56.31% in one year.
Market Cap
284.16M
Enterprise Value
48.77M
1-Year Change
-56.31%
Ranking
Category
Stock Price
$2.59
Market Cap Chart
Since July 24, 2020, Annexon's market cap has decreased from $639.51M to $284.16M, a decrease of -55.57%. That is a compound annual growth rate of -14.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2025 | 284.16M | -48.03% |
| Dec 31, 2024 | 546.82M | 53.75% |
| Dec 29, 2023 | 355.65M | 44.43% |
| Dec 30, 2022 | 246.25M | -44.15% |
| Dec 31, 2021 | 440.93M | -53.83% |
| Dec 31, 2020 | 955.09M | 49.35% |
| Jul 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 725.47B |
| Johnson & Johnson | 400.31B |
| AbbVie | 333.00B |
| Novo Nordisk | 311.87B |
| UnitedHealth Group | 255.92B |
| Novartis AG | 225.40B |
| AstraZeneca | 224.29B |
| Abbott Laboratories | 219.83B |